Anuh Pharma Limited — Board Meeting, 23-05-2025: Outcome of Board Meeting

Anuh Pharma has announced a board meeting on May 23, 2025, approving the audited financial results for the quarter and year ended March 31, 2025. Revenue climbed to ₹671 Cr, with PAT at ₹47.35 Cr for FY25. The board proposed a 1:1 bonus share issue (subject to shareholder approval) and a final dividend of ₹1.50 per share (30% payout on face value post-bonus). Joint Managing Directors Ritesh and Vivek Shah were reappointed for five years, signaling leadership stability ahead.